tradingkey.logo

赛诺菲

SNY
查看详细走势图
48.680USD
-0.180-0.37%
收盘 12/12, 16:00美东报价延迟15分钟
118.50B总市值
11.78市盈率 TTM

赛诺菲

48.680
-0.180-0.37%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.37%

5天

-1.72%

1月

-6.99%

6月

-1.99%

今年开始到现在

+0.93%

1年

+4.02%

查看详细走势图

TradingKey 赛诺菲股票评分

单位: USD 更新时间: 2025-12-12

操作建议

赛诺菲当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名69/159位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价61.88。中期看,股价处于平稳状态。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

赛诺菲评分

相关信息

行业排名
69 / 159
全市场排名
176 / 4592
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 9 位分析师
买入
评级
61.882
目标均价
+27.75%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

赛诺菲亮点

亮点风险
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
高分红
公司属于高分红公司,最新股息支付率171.67%
稳定分红
公司5年内连续分红,最新股息支付率171.67%
估值低估
公司最新PE估值11.78,处于3年历史低位
机构减仓
最新机构持股251.34M股,环比减少9.80%
理查德·皮兹纳持仓
明星投资者理查德·皮兹纳持仓,最新持仓市值6.67K

赛诺菲新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

赛诺菲简介

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
公司代码SNY
公司赛诺菲
CEOHudson (Paul)
网址https://www.sanofi.com/

常见问题

赛诺菲(SNY)的当前股价是多少?

赛诺菲(SNY)的当前股价是 48.680。

赛诺菲的股票代码是什么?

赛诺菲的股票代码是SNY。

赛诺菲股票的52周最高点是多少?

赛诺菲股票的52周最高点是60.115。

赛诺菲股票的52周最低点是多少?

赛诺菲股票的52周最低点是44.617。

赛诺菲的市值是多少?

赛诺菲的市值是118.50B。

赛诺菲的净利润是多少?

赛诺菲的净利润为6.01B。

现在赛诺菲(SNY)的股票是买入、持有还是卖出?

根据分析师评级,赛诺菲(SNY)的总体评级为买入,目标价格为61.882。

赛诺菲(SNY)股票的每股收益(EPS TTM)是多少

赛诺菲(SNY)股票的每股收益(EPS TTM)是4.133。
KeyAI